Sandbox Reserved 712: Difference between revisions
| Line 13: | Line 13: | ||
in the aspartyl protease.<ref> PMID:3290901 </ref> | in the aspartyl protease.<ref> PMID:3290901 </ref> | ||
Because of its importance for the life-cycle of the retrovirus, HIV- | Because of its importance for the life-cycle of the retrovirus, [[HIV-1 protease]]s are the major target for anti-HIV treatment. | ||
HIV protease inhibitors are the most potent agents used in anti-HIV treatment. However it appears that HIV-PRs develop a resistance to the inhibitor. <ref> PMID:12543689 </ref> | HIV protease inhibitors are the most potent agents used in anti-HIV treatment. However it appears that HIV-PRs develop a resistance to the inhibitor. <ref> PMID:12543689 </ref> | ||